Steven Cohn – Projects/Grants — UTMB Health Research Expert Profiles

View Scopus Profile

Emailsmcohn@utmb.edu

Research activity per year

If you made any changes in Pure these will be visible here soon.

1 Completed
7 Active

7 results

Filter

Active

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo and Active Controlled, Treat-Through study to Evaluate the Efficacy and Safety of Mirikizumab in Patients with Moderately to Severely Active Crohn's Disease
Cohn, S.
8/20/20 → 8/19/22
Project: Other project
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo and Active Controlled, Treat-Through study to Evaluate the Efficacy and Safety of Mirikizumab in Patients with Moderately to Severely Active Crohn's Disease
Cohn, S.
Eli Lilly
8/20/20 → 8/19/22
Project: Other project
Protocol I6T-MC-AMBG (a) A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients with Moderately to Severely Active Ulcerative Colitis - LUCENT 2
Cohn, S.
Eli Lilly & Company
5/13/20 → 5/12/25
Project: Other project
Protocol I6T-MC-AMBG (a) A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients with Moderately to Severely Active Ulcerative Colitis - LUCENT 2
Cohn, S.
5/13/20 → 5/12/25
Project: Other project
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients with Moderately to Severely Active Ulcerative Colitis.
Cohn, S.
Eli Lilly
2/27/20 → 2/26/25
Project: Other project
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients with Moderately to Severely Active Ulcerative Colitis.
Cohn, S.
2/27/20 → 2/26/25
Project: Other project
Corrona Inflammatory Bowel Disease (IBD) Registry
Cohn, S.
5/21/19 → 5/20/22
Project: Other project